Physician

Ali Akram Khan, MD

According to 2025 Medicare claims, Ali Khan, MD (NPI: 1356873012) practices advanced heart failure and transplant cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Richmond, NY. This provider's primary affiliated billing organization is CENTRA MEDICAL GROUP, LLC (NPI: 1649228966; TIN: 203639329) and primary practice location at 24501-1109.

Khan's data goes back to 2015 and runs through 2024. For example, in 2021, this provider had 141 traditional Medicare patients, billed 380 HCPCS/CPT codes, and received $30,425 in Medicare payments. 2024 Part D data shows 144 prescription claims across 49 beneficiaries totaling $17,372 in drug costs, led by Rosuvastatin Calcium (Rosuvastatin Calcium). Open Payments data shows 53 records totaling $5,385. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $11,153 and ending at $17,372. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$15K$30K2020 Medicare payment: $22,820 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $30,425 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020102277$22,820
2021141380$30,425
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$47K2017 Drug cost: $11,153 (USD; Tot_Drug_Cst)2018 Drug cost: $24,312 (USD; Tot_Drug_Cst)2019 Drug cost: $47,296 (USD; Tot_Drug_Cst)2020 Drug cost: $35,796 (USD; Tot_Drug_Cst)2021 Drug cost: $12,133 (USD; Tot_Drug_Cst)2022 Drug cost: $15,341 (USD; Tot_Drug_Cst)2023 Drug cost: $12,507 (USD; Tot_Drug_Cst)2024 Drug cost: $17,372 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201724161$11,153
201871466$24,312
201986723$47,296
202085449$35,796
202136137$12,133
202261168$15,341
202365223$12,507
202449144$17,372

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Rosuvastatin CalciumRosuvastatin Calcium161,080$402
Metoprolol SuccinateMetoprolol Succinate181,230$360
Losartan PotassiumLosartan Potassium211,290$239

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.53$5,385Inari Medical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ali Akram Khan, MD?

Tedicare shows public-source Medicare data for Ali Akram Khan, MD (NPI 1356873012), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Akram Khan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Akram Khan, MD?

Ali Akram Khan, MD is linked to CENTRA MEDICAL GROUP, LLC (billing NPI 1649228966) in the available physician profile data.

Does Ali Akram Khan, MD have Open Payments data?

Ali Akram Khan, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.